SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,459.53 308.49
( 0.42%)

Global Indices

Nasdaq

51,732.40 -631.16
(-1.21%)

Dow Jones

7,581.68 -159.71
(-2.06%)

Hang Seng

63,176.05 -1,483.42
(-2.29%)

Nikkei 225

10,722.51 0.44
(0.00%)

Forex

USD-INR

95.22 0.06
(0.06%)

EUR-INR

106.19 0.24
(0.23%)

GBP-INR

127.01 0.44
(0.35%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2311355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

56.23

4133.65

EPS(TTM)

Face Value()

Div & Yield %

7.33

0.02

Back

genpharmasec limited

Wockhardt reports consolidated net profit of Rs 106.00 crore in the June 2026 quarter

Aug 10,2026

Net profit of Wockhardt reported to Rs 106.00 crore in the quarter ended June 2026 as against net loss of Rs 90.00 crore during the previous quarter ended June 2025. Sales rose 25.88% to Rs 929.00 crore in the quarter ended June 2026 as against Rs 738.00 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	929.00	738.00	26
OPM %	20.67	9.76	-
PBDT	171.00	44.00	289
PBT	116.00	-12.00	LP
NP	106.00	-90.00	LP

74,459.53 308.49 ( 0.42%)

51,732.40 -631.16 (-1.21%)

7,581.68 -159.71 (-2.06%)

63,176.05 -1,483.42 (-2.29%)

10,722.51 0.44 (0.00%)

95.22 0.06 (0.06%)

106.19 0.24 (0.23%)

127.01 0.44 (0.35%)

0.60 0.00 (0.12%)